The Lawyer’s newest product is the most comprehensive overview of the Asia-Pacific legal market yet produced. With rankings of the top 100 local law firms by lawyer headcount as well as analysis of the leading 50 international players in the region, it is essential reading for anyone interested in the strategic future of the world’s fastest growing legal market
Merck is a longstanding Fried Frank client. In 2004 partners Shine, David Shapiro and Jonathan Lewis advised the pharmaceutical company on its acquisition of Aton Pharma.
On the Schering Plough acquisition Shearman & Sterling’s New York-based partners Peter Lyons, Jessica Nielsen and Eliza Swann led the team advising Morgan Stanley as underwriter, while Sullivan & Cromwell partners George Sampas and Stephen Kotran advised co-underwriter Goldman Sachs.
The deal comes at a time of consolidation in the pharmaceuticals industry.
Earlier this year (26 January) The Lawyer reported that Cadwalader Wickersham & Taft partner Dennis Block led the firm’s team that advised Pfizer on its $68bn (£49.42bn) takeover of rival Wyeth.
Simpson Thacher & Bartlett partner Casey Cogut advised Wyeth on the deal. Wachtell also had a role on the Wyeth deal, advising the company’s directors.
Last summer (22 July 2008) The Lawyer reported on Davis Polk & Wardwell client Roche’s $45.7bn (£33.22bn) bid for Genentech. Genentech instructed longstanding adviser Latham & Watkins.